Athersys Appoints Neema Mayhugh, PhD to its Board of Directors
Healthcare Executive and Strategy Consultant Brings Considerable Innovation, Commercialization and Entrepreneurial Expertise ...
Source: marketscreener.com
📰 Athersys Inc News
Page 8 - Athersys Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Athersys Inc. Real-time updates on events, politics, business and more.
Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session - a.k.a. Brands Holding (NYSE:AKA), Akumin (NASDAQ:AKU)
Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results.
Brendan Hoffman Applovin Corporation Raymond James Missfresh Limited Matinas Biopharma Holdings Inc Carrols Restaurant Group Inc
Source: benzinga.com
Athersys (ATHX) Set to Announce Earnings on Wednesday
Athersys (NASDAQ:ATHX – Get Free Report) will announce its earnings results on Wednesday, August 9th. Athersys (NASDAQ:ATHX – Get Free Report) last announced its quarterly earnings data on Monday, May 15th. The biopharmaceutical company reported ($0.43) earnings per share for the quarter. Athersys Stock Down 20.4 % Shares of ATHX stock opened at $0.48 on […]
Athersys Company Profile Asset Management Inc Athersys Inc Pricet Rowe Associates Inc Advisor Group Virtu Financial
Source: modernreaders.com
Athersys (NASDAQ:ATHX) Now Covered by StockNews.com
StockNews.com assumed coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report report published on Monday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Athersys Stock Down 4.1 % ATHX stock opened at $0.65 on Monday. The firm has a market capitalization of $11.94 million, a PE ratio […]
Athersys Company Profile Advisor Group Asset Management Inc Pricet Rowe Associates Inc Athersys Inc Simplicity Solutions
Source: modernreaders.com
Athersys to Host Business Update Conference Call on August 9th
Athersys, Inc. , a cell therapy and regenerative medicine company developing MultiStem® for critical care indications, announced today it will host a business update conference call on August 9,...
Source: marketscreener.com
Athersys : Failure to Satisfy Listing Rule
Athx-20230728 UNITED STATES SECURITIES AND...
United States Daniel Camardo Athersys Inc Nasdaq Stock Market Nasdaq Hearings Panel Listing Qualifications Department
Source: marketscreener.com
Athersys (NASDAQ:ATHX) Now Covered by StockNews.com
StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research note issued to investors on Friday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Athersys Stock Performance Shares of NASDAQ:ATHX opened at $0.83 on Friday. The company has a market cap of $15.38 million, a PE ratio […]
Advisor Group Renaissance Technologies Vanguard Group Inc Charles Schwab Investment Management Inc Athersys Inc Sequoia Financial Advisors
Source: wkrb13.com
Acute Ischemic Stroke Therapeutics Market to grow by USD 1,524.49 million from 2022 to 2027|Rising prevalence of disease boosts the market
/PRNewswire/ -- The global acute ischemic stroke therapeutics market size is estimated to grow by USD 1,524.49 million from 2022 to 2027, according to...
Source: prnewswire.com
Athersys (NASDAQ:ATHX) Receives New Coverage from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a report issued on Friday. The firm issued a hold rating on the biopharmaceutical company’s stock. Athersys Stock Performance Shares of NASDAQ:ATHX opened at $0.85 on Friday. The company has a market cap of $15.68 million, a PE ratio of -0.18 and a […]
Jacobs Levy Equity Management Inc Renaissance Technologies Millennium Management Vanguard Group Inc Athersys Inc Jpmorgan Chase Co
Source: etfdailynews.com
Athersys : Shareholder Director Nominations
Athx-20230628 UNITED STATES SECURITIES AND...
Source: marketscreener.com